99 related articles for article (PubMed ID: 8876160)
1. Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation.
McPhee F; Good AC; Kuntz ID; Craik CS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11477-81. PubMed ID: 8876160
[TBL] [Abstract][Full Text] [Related]
2. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.
Babé LM; Rosé J; Craik CS
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10069-73. PubMed ID: 7479728
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.
Luukkonen BG; Fenyö EM; Schwartz S
Virology; 1995 Feb; 206(2):854-65. PubMed ID: 7856098
[TBL] [Abstract][Full Text] [Related]
4. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
[TBL] [Abstract][Full Text] [Related]
5. Yeast two-hybrid assay for examining human immunodeficiency virus protease heterodimer formation with dominant-negative inhibitors and multidrug-resistant variants.
Todd S; Laboissière MC; Craik CS
Anal Biochem; 2000 Jan; 277(2):247-53. PubMed ID: 10625514
[TBL] [Abstract][Full Text] [Related]
6. Macromolecular inhibitors of HIV-1 protease. Characterization of designed heterodimers.
Rozzelle JE; Dauber DS; Todd S; Kelley R; Craik CS
J Biol Chem; 2000 Mar; 275(10):7080-6. PubMed ID: 10702274
[TBL] [Abstract][Full Text] [Related]
7. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
Cherry E; Morin N; Wainberg MA
AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
[TBL] [Abstract][Full Text] [Related]
8. Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model.
Wang W; Kollman PA
J Mol Biol; 2000 Nov; 303(4):567-82. PubMed ID: 11054292
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization.
Song R; Kafaie J; Yang L; Laughrea M
J Mol Biol; 2007 Aug; 371(4):1084-98. PubMed ID: 17599354
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
11. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.
Bleiber G; Munoz M; Ciuffi A; Meylan P; Telenti A
J Virol; 2001 Apr; 75(7):3291-300. PubMed ID: 11238855
[TBL] [Abstract][Full Text] [Related]
12. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
[TBL] [Abstract][Full Text] [Related]
13. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Koh Y; Matsumi S; Das D; Amano M; Davis DA; Li J; Leschenko S; Baldridge A; Shioda T; Yarchoan R; Ghosh AK; Mitsuya H
J Biol Chem; 2007 Sep; 282(39):28709-28720. PubMed ID: 17635930
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity.
Kräusslich HG
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3213-7. PubMed ID: 2014242
[TBL] [Abstract][Full Text] [Related]
17. Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.
Kaplan AH; Manchester M; Smith T; Yang YL; Swanstrom R
J Virol; 1996 Sep; 70(9):5840-4. PubMed ID: 8709202
[TBL] [Abstract][Full Text] [Related]
18. A folding inhibitor of the HIV-1 protease.
Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
[TBL] [Abstract][Full Text] [Related]
19. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
Kafaie J; Dolatshahi M; Ajamian L; Song R; Mouland AJ; Rouiller I; Laughrea M
Virology; 2009 Mar; 385(1):233-44. PubMed ID: 19070880
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
